Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Other Operating Expenses (2025)

Crinetics Pharmaceuticals (CRNX) has 1 years of Other Operating Expenses data on record, last reported at $1.1 million in Q4 2025.

  • For Q4 2025, Other Operating Expenses changed N/A year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, changed N/A, while the annual FY2025 figure was $1.1 million, N/A changed from the prior year.
  • Other Operating Expenses reached $1.1 million in Q4 2025 per CRNX's latest filing.
  • Across five years, Other Operating Expenses topped out at $1.1 million in Q4 2025 and bottomed at $1.1 million in Q4 2025.